問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol Number1378-0020
Active

2024-07-30 - 2028-09-30

Phase III

Not yet recruiting8

Recruiting2

ICD-10I50.20

Unspecified systolic (congestive) heart failure

ICD-10I50.21

Acute systolic (congestive) heart failure

ICD-10I50.22

Chronic systolic (congestive) heart failure

ICD-10I50.23

Acute on chronic systolic (congestive) heart failure

ICD-10I50.30

Unspecified diastolic (congestive) heart failure

ICD-10I50.31

Acute diastolic (congestive) heart failure

ICD-10I50.32

Chronic diastolic (congestive) heart failure

ICD-10I50.33

Acute on chronic diastolic (congestive) heart failure

ICD-10I50.40

Unspecified combined systolic (congestive) and diastolic (congestive) heart failure

ICD-10I50.41

Acute combined systolic (congestive) and diastolic (congestive) heart failure

ICD-10I50.42

Chronic combined systolic (congestive) and diastolic (congestive) heart failure

ICD-10I50.43

Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure

ICD-10I50.9

Heart failure, unspecified

ICD-9428.0

Congestive heart failure

  • Trial Applicant

    IQVIA RDS Taiwan Ltd.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator Tsung-Hsien Lin Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator JIN–LONG HUANG Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 張鴻猷 Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Yen-Wen Wu Division of Cardiovascular Diseases

Co-Principal Investigator

  • 張藝耀 Division of Cardiovascular Diseases
  • 曾炳憲 Division of Cardiovascular Diseases
  • 許榮城 Division of Cardiovascular Diseases
  • 林恆旭 Division of Cardiovascular Diseases
  • 黃繼正 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Chun-Yao Huang Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Tzung-Dau Wang Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 李統立 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 蔡幸珊 Division of Cardiovascular Diseases
  • 梁懷文 Division of Cardiovascular Diseases
  • 宣錦峰 Division of Cardiovascular Diseases
  • 曾維功 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Pao-Hsien Chu Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Kuan-Cheng Chang Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    150 participants

  • Global

    6000 participants